E1A signaling to p53 involves the p19<sup>ARF</sup>tumor suppressor

Elisa de Stanchina(Memorial Sloan Kettering Cancer Center), Scott Lowe(Memorial Sloan Kettering Cancer Center)

Genes & Development

August 1, 1998

10.1101/gad.12.15.2434

Cited by 610

Related Papers

Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling

|Science Translational Medicine|2011|530

Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor

|Nature|2016|483

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer

|Cancer Cell|2020|252

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

|Cancer Discovery|2020|159

The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer

|Immunity|2022|123